Healthtech & Wellness VC Funds

Correlation Ventures, founded in 2006 and based in San Francisco, leverages predictive analytics to make investment decisions, positioning itself as a unique player in the venture capital landscape. With over 519 investments, the firm has backed notable companies such as IonQ, MosaicML, Imperfect Foods, and Personal Capital. Their innovative approach allows them to make rapid investment decisions, typically within two weeks, without traditional due diligence, making them a preferred co-investor for many lead venture capitalists​​. Correlation Ventures typically invests between $1 million and $4 million, focusing on diverse sectors including AI, fintech, healthcare, and consumer products. Their portfolio is characterized by a high level of diversification, including early investments in companies that have achieved significant exits such as Synthorx, which was acquired by Sanofi for $2.5 billion, and Personal Capital, acquired by Empower for $875 million​​. The firm was co-founded by David Coats and Trevor Kienzle, who continue to lead the team alongside key figures like Wesley Barrow and Grace Chui-Miller. With offices in San Francisco, San Diego, and New York City, Correlation Ventures continues to expand its influence by applying data-driven insights to support its investment strategy and portfolio growth​.

Cortado Ventures, established in 2020 and headquartered in Oklahoma City, is an early-stage venture capital firm focused on investing in growth-driven startups across industries like fintech, biotech, aerospace, energy tech, and manufacturing. Their mission is to foster innovation in the Midcontinent region, supporting entrepreneurs who leverage technology to solve critical problems. Notable investments include PatchRx, which streamlines medication adherence, and Moat Biotechnology, a company developing life-saving intranasal vaccines. Cortado primarily invests in B2B companies, typically at the seed stage, and aims to accelerate their growth through hands-on support and strategic guidance. Co-founded by David Woods and Michael Moradi, the firm prides itself on providing rapid decision-making and a high degree of flexibility, which sets them apart from traditional venture capital models. Their focus on long-term relationships and nurturing local talent has positioned Cortado Ventures as a key player in the Midcontinent region’s entrepreneurial ecosystem.

Cosmic Venture Partners, founded in 2021 and based in New York, is an early-stage venture capital firm. The firm focuses on investing in next-generation startups, particularly those operating in the tech, Web3, and consumer packaged goods (CPG) sectors. Cosmic Venture Partners aims to support innovative platforms, products, and services that have the potential to transform their respective industries. The firm was co-founded by Alexandra Tynion, Brian McNamara, and Matthew Rutler. Alexandra Tynion, who has experience with SeedInvest and Circle Financial, is based in New York City. Brian McNamara, with an MBA from Columbia Business School and a background at Jefferies, operates out of Austin, Texas. Matthew Rutler, an angel investor in over 100 startups and an EVP at MasterClass, is based in Los Angeles. Cosmic Venture Partners has made several notable investments, including GarageXYZ in the automotive sector and Goodles in food products. The firm has also achieved successful exits, such as the buyout of Nue Life and the acquisition of Kangaroo​. The firm's ethos centers on partnering with visionary founders who are not only imagining the future but actively building it. Cosmic Venture Partners provides both capital and strategic support, leveraging their extensive network and industry expertise to help startups scale and succeed.

Cota Capital, founded in 2015 and based in San Francisco, is a multi-stage investment firm focusing on enterprise technology. The firm aims to support companies through both private and public investments, leveraging a strategic and operational approach to drive growth. Cota Capital invests in sectors such as AI, cloud computing, fintech, and cybersecurity, with notable portfolio companies including OpenGov and Mission Bio. Led by founder Bobby Yazdani, Cota Capital emphasizes a partnership model, working closely with portfolio companies to build long-term value. Their investment range typically covers early to growth stages, providing substantial support to innovative ventures​.

Cottonwood Technology Fund is a venture capital firm specializing in seed and early-stage investments in technology-driven businesses. With offices in Santa Fe, New Mexico, and Enschede, the Netherlands, the fund focuses on sectors such as chemistry and material sciences, photonics, robotics, medical technology, and clean energy. Their investment strategy targets hard science and deep tech startups, providing crucial support for commercialization and global scaling. Notable investments include companies like Skorpios Technologies, BayoTech, Respira Therapeutics, Infinitum Electric, and Exagen. Cottonwood is known for its hands-on approach, offering more than just financial backing by actively helping with strategy alignment, market entry, and connecting portfolio companies with potential customers and strategic partners. The firm’s team, led by Managing Director Dave Blivin and General Partner Alain le Loux, brings diverse expertise and a strong entrepreneurial mindset, making Cottonwood a valuable partner for startups in their portfolio.

COTU Ventures is a Dubai-based early-stage venture capital firm focused on investing in startups across the Middle East and North Africa (MENA) region. Founded in 2021, the firm has raised a $54 million fund to back exceptional founders, particularly those at the pre-seed and seed stages. COTU emphasizes being the first institutional investor, helping startups navigate the most challenging early stages of growth. COTU Ventures typically makes initial investments ranging from $500,000 to $1.5 million, with the flexibility to follow on in later rounds. They are committed to working with a small number of portfolio companies per fund, which allows them to provide deep, hands-on support. Their investment approach is driven by building strong relationships with founders and assisting in critical areas like product development, strategy, and talent acquisition. The firm focuses primarily on the GCC, Egypt, Lebanon, and Jordan, and backs startups in diverse sectors. Notable portfolio companies include Supy and MoneyHash, which reflect COTU’s interest in fragmented, fast-growing markets. COTU Ventures stands out for its commitment to the MENA region, aiming to help build a thriving entrepreneurial ecosystem.

Coughdrop Capital is an early-stage venture capital firm founded by brothers Stu and Austin Smith in 2015. Based in Bend, Oregon, with a presence in San Francisco and Los Angeles, the firm typically invests $25-50K in pre-seed and seed-stage startups across various sectors. Their investment philosophy centers on backing smart, ambitious founders regardless of the industry​. The firm has a diverse portfolio that includes notable investments in companies such as Superhuman, Lattice, Mercury, Ware, Dreamship, Ever Loved, Housable, Fast, and Catch. Coughdrop Capital is known for its founder-friendly approach, often providing strategic guidance, valuable introductions, and operational support to its portfolio companies​. Stu Smith brings extensive experience from his roles at WarnerMedia and Teespring, focusing on driving innovation in the entertainment and media sectors. Austin Petersmith, on the other hand, is the founder and CEO of Capiche, a platform for honest conversations about SaaS, and has a background in growth and marketing roles at early-stage startups​. Coughdrop Capital's investment strategy emphasizes quick decision-making and maintaining a supportive relationship with founders. They have been praised for their helpfulness, integrity, and ability to stay out of the way when not needed, while being available to offer support and resources when required.

Courage Ventures is a Helsinki-based venture capital firm founded in 2014, specializing in early-stage digital health startups across the Nordic and Baltic regions. The firm backs companies at pre-seed and seed stages with checks ranging from $250,000 to $1 million, and invests with a particular mandate: bringing Nordic digital health innovation to the world, with specific emphasis on facilitating entry into the US healthcare market. Seed Fund 1, a 2016 vintage vehicle, spans investments across Northern Europe and the United States. Across 17 investments, Courage has backed companies in health technology, AI, education, and sustainability. Notable portfolio companies include Meru Health, a digital mental health platform, and CosmEthics. The firm also invested in Aivo. The seven-person team — comprising four partners and three venture partners located in Finland and the United States — brings geographic presence in both source and target markets for the firm's cross-border commercialization thesis. Investment focus spans Estonia, Finland, Latvia, and Lithuania. Courage leads its rounds, bringing not just capital but active support in translating Nordic health technology innovations into the US regulatory and commercial environment. The firm's thesis rests on a specific advantage: the Nordic countries produce high-quality digital health companies in healthcare systems known for rigorous data standards and patient outcomes, making them credible candidates for the evidence-demanding US market. Courage positions itself as the bridge between these ecosystems.

Courtside Ventures is a leading early-stage venture capital firm specializing in sports, lifestyle, and gaming investments. Founded by Vasu Kulkarni, the firm is headquartered in New York City. Courtside has a strong portfolio, including notable companies like The Athletic, StockX, and 100 Thieves. Their focus is on businesses at the intersection of sports, media, and technology, reflecting a keen interest in the content creation, distribution, and monetization spaces. With three funds totaling over $200 million in assets under management, Courtside Ventures has made over 80 active investments. They typically participate in Seed and Series A rounds, often leading the funding efforts. The firm’s geographic focus spans both the U.S. and international markets, with about 20% of their investments located outside the U.S. Courtside Ventures employs a strategic approach, prioritizing startups that can demonstrate significant potential in their niche markets. They look for passionate entrepreneurs and innovative business models that can drive growth in sports tech, wellness, and gaming. Noteworthy team members include Vasu Kulkarni, Deepen Parikh, and Kai Bond, each bringing extensive experience and a deep network in their respective fields. For startups seeking to connect with Courtside Ventures, it's crucial to present a clear vision aligned with the firm’s core investment themes. They appreciate pitches that highlight unique value propositions and scalable business models that can thrive in the ever-evolving landscape of sports, lifestyle, and gaming.

Covalent Ventures is a globally connected food and health impact investor founded in 2021 and headquartered in Auckland, New Zealand, with additional presence in Switzerland. The firm focuses on Series A health and wellness investments, actively working with portfolio companies to scale into major global markets across the Asia-Pacific region, Switzerland, and the United States. Partner Kelvin Keh brings more than 20 years of international healthcare experience spanning biotech and pharma, medical devices, digital health, nutrition, and consumer packaged goods. The combined investment team holds 50 or more years of sector experience and a track record of at least 17x growth. Covalent deploys checks of $500,000 to $4 million per company with a sweet spot of $2 million, investing across seed through Series B stages in 11 portfolio companies. Sector coverage spans food systems, nutrition science, biotech, pharmaceutical, medical devices, digital health, healthcare systems, novel ingredients, and cell and gene therapy — a deliberately broad mandate within the health and food impact thesis. The firm's investment philosophy holds that human health is inseparable from food systems, and that the most consequential companies in this space bridge both domains. Covalent works alongside founders to access green and brownfield markets — new categories as well as established markets ripe for disruption — bringing sector expertise and a global network to bear on the commercial challenges that health and food technology companies face as they scale from early traction to institutional scale.

Covenant Venture Capital is a New York-based firm focused on high-potential, growth-stage companies, particularly in technology sectors like AI, aerospace, and enterprise applications. Founded in 2020, Covenant's portfolio features notable investments in companies such as Anduril, a defense technology leader, and Zipline, a pioneer in drone delivery services. Covenant has a reputation for supporting unicorns, with Anduril and Zipline both achieving billion-dollar valuations. Covenant takes a strategic approach, balancing high-reward investments with risk management, often structuring credit investments to complement their equity portfolio. They have raised multiple funds and are known for their strong ties with institutional investors, including pension funds and endowments. Led by a small team of four partners, Covenant places a strong emphasis on working closely with its portfolio companies, providing not only capital but also strategic guidance to help them scale. They primarily invest in the U.S., though their portfolio also includes international ventures, demonstrating their global outlook.

Cowboy Ventures, founded in 2012 by Aileen Lee, is a Palo Alto-based venture capital firm that focuses on seed-stage investments. The firm supports innovative startups aiming to transform large markets through technology. Among Cowboy Ventures' notable investments is Guild, a platform reimagining education and skilling for working adults. Another key investment is Drata, which provides automated compliance for security frameworks, helping businesses ensure they meet necessary standards efficiently. Homebase is another significant investment, a SaaS platform that assists small businesses in managing their teams more effectively. Additionally, Cowboy Ventures has backed Vic.ai, an AI-driven company enhancing accounting and finance processes, and Ironclad, which offers comprehensive contract lifecycle management software. The firm has seen successful exits with companies like Dollar Shave Club, a subscription-based grooming products company; August Home, which develops smart home products; and NuORDER, a wholesale e-commerce platform. Recently, they have invested in CapStack Technologies, a fintech startup focusing on bank-to-bank transactions, and Getaway, which operates in the real estate tech space. Cowboy Ventures emphasizes a hands-on approach, helping portfolio companies with key hires, product development, go-to-market strategies, and preparing for future funding rounds.

Co-Win Ventures, founded in 2009 and based in Beijing, China, is a prominent early-stage investment firm focusing on the Technology, Media, and Telecommunications (TMT) and healthcare sectors. Their portfolio features a variety of innovative companies, including KBP Biosciences, Celsius Therapeutics, Thrive Earlier Detection, and Fluent BioSciences. The firm supports both early-stage and growth-stage companies, providing capital and strategic guidance to help them scale successfully. Co-Win Ventures has a strong presence in both China and the USA, leveraging its extensive network to foster innovation and growth. Their investment approach combines financial backing with hands-on support, ensuring that their portfolio companies have the resources they need to thrive in competitive markets. By focusing on sectors with high growth potential, Co-Win Ventures aims to drive advancements in technology and healthcare, contributing to significant industry developments. Their commitment to supporting visionary entrepreneurs has made them a key player in the venture capital landscape.

Coyote Ventures is a venture capital firm focused on early-stage investments in women’s health and wellness startups. Founded in 2021 by Jessica Karr, the firm aims to address the significant underinvestment in women’s health, a market estimated to exceed $1 trillion globally. Coyote Ventures backs innovative consumer and digital health companies, particularly those solving problems that disproportionately affect women and underserved populations. With a portfolio that includes companies like Wile (hormonal wellness), Hera Biotech (endometriosis diagnostics), and Flex (cycle care), Coyote Ventures is building a synergistic pipeline in the rapidly growing femtech sector. The firm’s investment strategy prioritizes founders with deep expertise and lived experience, ensuring solutions are both impactful and practical. Additionally, all of the portfolio companies have female CEOs, with many co-founders being BIPOC or LGBTQ+. Coyote Ventures’ inaugural fund has attracted backing from prominent investors, including Bank of America, The Case for Her, and Tripple Family Office, solidifying its position as a key player in the health and wellness investment space. By championing women-led innovations, Coyote Ventures aims to drive systemic change in how healthcare is designed and delivered for women.

CP Ventures is a Sydney-based venture capital fund founded in 2018 that backs the world's best companies in their niche — highly scalable, breakthrough technology startups operating at the frontier of their categories. The fund manages approximately $14 million in assets and is led by a team of 10, including three partners, who have collectively made more than 100 personal angel and fund investments globally. The firm invests primarily at pre-seed and seed stages with checks ranging from $100,000 to $500,000, with a portfolio of 38 companies concentrated in Australian startups but extending globally. CP Ventures deploys capital across AI, healthtech, fintech, biotechnology, SaaS, and B2B services, with geographic reach spanning Australia, the United States, New Zealand, India, Singapore, Hong Kong, Colombia, and Brazil. The fund does not lead rounds but participates as a high-conviction early supporter, positioning alongside founders who are building businesses with the potential to dominate their specific niche rather than competing across broad horizontal markets. The firm's stated mission is to be the fund of choice for world-changing startups and the investors who want to empower them, combining skilled people, a collaborative culture, and what it describes as pioneering processes and technology. This early-stage, globally distributed approach reflects a conviction that breakthrough technology companies emerge across multiple geographies and that access to early Australian and Asia-Pacific founders — before they have significant US investor coverage — creates a structural sourcing advantage.

CPT Capital, based in London, is the venture capital arm of a leading private family office. The firm specializes in investing in companies revolutionizing the food and materials technology sectors, particularly in the realm of alternative proteins. CPT Capital's mission is to drive this revolution by partnering with visionary founders and supporting them from pre-seed stages through to IPO or sale. As a long-standing investor in the alternative protein space, CPT Capital focuses on plant-based proteins, biomass fermentation, recombinant proteins, and cultivated meat. Their portfolio includes groundbreaking companies like Impossible Foods, Beyond Meat, and Upside Foods, all of which are at the forefront of developing sustainable and innovative food solutions. CPT Capital seeks companies with products that directly replace animal-derived products and possess a strong technological or intellectual property component. The firm is geographically diverse, with investments spanning the US, Israel, Europe, the UK, and Asia. The firm is dedicated to addressing global challenges related to food production and sustainability, aiming to replace traditional animal protein sources with more sustainable alternatives. This approach not only promises environmental benefits but also aims to improve public health and resource efficiency.

Craft Ventures is a venture capital firm that focuses on early-stage investments in B2B software, marketplaces, and transaction-based business models. Established in 2017, Craft Ventures is led by a team of seasoned entrepreneurs and investors, including Jeff Fluhr, co-founder of StubHub, and David Sacks, former COO of PayPal. Craft Ventures' strategy includes providing more than just capital. They offer strategic support to portfolio companies, helping them build robust go-to-market strategies, optimize operations, and scale effectively. Their team comprises individuals with extensive experience in marketing, growth, and operations from successful tech startups like ClickUp and Callin. With a presence in San Francisco and a commitment to working closely with founders, Craft Ventures aims to identify and support the next generation of category-defining companies.

CRCM Ventures is a venture capital firm founded in 2004, headquartered in San Francisco, with a focus on early-stage investments in both the US and Greater China. The firm targets sectors such as healthcare and wellness, fintech, blockchain technology, media, and frontier technology. CRCM Ventures has an impressive portfolio, including three unicorns: Apollo, Blockdaemon, and Iterable. Notable public companies in their portfolio include Ginkgo Bioworks, which went public on the NYSE in 2021, and Yiju Enterprise Group, listed on the Hong Kong Stock Exchange. Additionally, CRCM has seen multiple acquisitions, such as The Drone Racing League and Spin, reflecting their success in identifying and supporting high-potential startups. The firm is led by a team of experienced professionals, including Chun Ding, who is based in San Francisco. Their investment strategy emphasizes backing innovative technology-driven companies with the potential to transform industries. CRCM Ventures combines a strong presence in Silicon Valley with deep connections in China, leveraging their dual-market expertise to drive growth and innovation in their portfolio companies. This approach allows them to provide significant value to startups looking to expand and scale their operations globally.

Creadev, established in 2002 and supported by the Mulliez family, is a global evergreen investment firm dedicated to nurturing companies that have the potential to become industry leaders. With a presence in Paris, Shanghai, New York, and Nairobi, Creadev has built a diverse portfolio across healthcare, sustainable consumption, and food sectors. One of their notable investments is Twiga Foods, a prominent food distribution platform in Kenya that uses technology to streamline the supply chain between farmers and vendors, enhancing efficiency and sustainability. Another significant investment is Victory Farms, an East African aquaculture platform addressing nutritional security through sustainable fish farming solutions. Creadev has also backed Everytable, a U.S.-based food and beverage company committed to providing affordable and healthy meals to underserved communities. In the realm of plant-based foods, Creadev has invested in The Jackfruit Company, which produces meat substitutes using jackfruit, catering to the growing demand for sustainable and healthy food options. Additionally, they support Lifen, a French health tech company offering digital solutions to improve healthcare delivery and patient management. Creadev's investment approach emphasizes long-term commitment and aligns the investment horizon with the entrepreneurial vision. They often lead funding rounds and work collaboratively with other investors to support the growth and expansion of their portfolio companies. This strategy reflects their dedication to fostering sustainable and impactful businesses globally​.

Cream City Venture Capital is a corporate venture capital fund backed by Northwestern Mutual, founded in 2017 and based in Milwaukee, Wisconsin. The fund invests exclusively in technology startups headquartered in southeast Wisconsin, backing founders who bring a deep point of view on the problems they are solving and the vision to see those solutions through. Northwestern Mutual has committed $15 million to the fund, with the initial $5 million investment followed by an additional $10 million to expand its regional impact. The fund targets Seed and Series A companies across software, SaaS, fintech, healthtech, and AI, writing initial checks of $100,000 to $250,000. With 14 investments completed, Cream City has built a portfolio spanning multiple technology verticals within the Wisconsin ecosystem. The firm's check size is flexible for the right teams, prioritizing conviction over formula. Craig Schedler, Venture Partner, Managing Director, and Founder, and Stig Haagensen, Senior Director of Digital Innovation at Northwestern Mutual, lead the fund's operations. Beyond capital, Cream City provides portfolio companies access to Northwestern Mutual's broader corporate ecosystem — including distribution relationships, operational networks, and strategic guidance — at critical growth inflection points.

Creandum is a leading European venture capital firm that specializes in early-stage investments, focusing on technology-driven companies within the consumer, software, and hardware industries. Founded in 2003, Creandum operates from its hubs in Stockholm, Berlin, London, and San Francisco, and is renowned for its thesis-driven approach to investing. The firm's notable portfolio includes high-profile companies such as Spotify, Klarna, Bolt, Depop, and Kahoot!. Creandum has also recently raised its seventh fund, a €500 million vehicle dedicated to supporting seed and early-stage startups across Europe. This fund aims to continue backing innovative companies poised to become global leaders. Creandum's investment philosophy emphasizes long-term commitment to founders, supporting them through the various stages of their growth journey. The firm prides itself on its deep industry expertise and extensive network, which it leverages to help startups scale and succeed in competitive markets. Recent investments include companies like Prewave, a supply chain disruption solution, and Plancraft, a platform digitizing work processes in the craft industry.

Creathor Ventures is one of Germany's most established early-stage venture capital firms, founded in 2003 and headquartered in Bad Homburg with an additional office in Meilen, Switzerland. Managing over €230 million in fund volume, the firm focuses on technology-oriented companies driving industrial automation and the digitalization of healthcare. With roots in venture investing stretching back to 1984, the management team has financed more than 200 companies over three decades, making Creathor one of the longest-tenured active investors in the German-speaking tech ecosystem. Creathor leads and co-leads rounds at Seed and Series A stages, deploying checks in the €3 million to €15 million range. The firm's 96-company portfolio is concentrated in enterprise applications, life sciences, and SaaS, with AI and hardware also well represented. More than 20 portfolio companies have reached international stock exchange listings, and numerous others have completed trade sales — a track record that underlines the firm's ability to build durable technology businesses. Operating across Germany and Switzerland with a team of 15, Creathor works closely alongside portfolio companies rather than from a distance. The firm's dual expertise in enterprise technology and healthcare gives it a distinctive vantage point for identifying companies where automation and digital tools are reshaping both industry and patient outcomes.

Creative Destruction Lab (CDL) is a global nonprofit organization designed to accelerate seed-stage, science-based companies towards massive scalability. Founded in 2012 at the University of Toronto’s Rotman School of Management, CDL operates 13 locations worldwide, including Toronto, New York, and London, among others. CDL runs 20 specialized streams targeting various sectors, such as Artificial Intelligence, Quantum Computing, Health, and Space. Notable startups that have emerged from CDL include Waabi, an autonomous trucking startup founded by AI expert Raquel Urtasun, which raised $200 million in Series B funding, and OTI Lumionics, an advanced materials company that secured $55 million in funding from top investors​​. CDL’s structured program offers intensive mentorship from successful entrepreneurs, scientists, and investors. It includes objective-setting sessions and tailored support to help startups refine their strategies, prioritize resources, and raise capital. This approach has proven highly effective, with CDL graduates achieving significant milestones and contributing to advancements in their respective fields.

Creative Ventures is a venture capital firm focusing on market-driven deep technology investments. They invest in early-stage B2B companies that are commercializing novel scientific and engineering innovations. Key investment sectors include climate change adaptation and mitigation, healthcare, and addressing labor shortages in industrial and service sectors. The firm prides itself on a market-first approach, ensuring that the technologies they invest in are primed to meet existing market demand rather than speculative future needs. This strategy helps mitigate risks associated with deep tech investments​ (Creative Ventures)​​ (Creative Ventures)​. Creative Ventures has been a lead or co-lead investor in 80% of their investments from the current fund, often being the first institutional investor on a company's cap table​. Notable portfolio companies include Path Robotics, Sepion Technologies, and OncoPrecision, which focus on autonomous welding robots, advanced materials for energy storage, and oncology drug efficacy, respectively​. The team, led by General Partners Alex Luce and Kulika Weizman, brings extensive expertise in areas such as material science, synthetic biology, and biotechnology.

Creator Fund is a venture capital firm focused on backing scientific founders at the pre-seed and seed stages, primarily across the UK and Europe. Founded in 2019 by Jamie Macfarlane, the fund specializes in investing in deep technology and life sciences startups that emerge from university research. With a unique model, Creator Fund operates a network of PhD students across 25+ leading European universities, helping to identify promising ventures at the earliest stages of development. Creator Fund typically invests between £100,000 to £700,000 in early-stage startups, often backing companies where at least one founder is an academic—whether a professor, PhD, or recent graduate. They have built a diverse portfolio, including companies like Baseimmune (biotechnology) and Recycleye (AI-driven waste management). Their sector focus spans deep tech areas such as artificial intelligence, robotics, quantum computing, and biotech, aiming to support founders who are pioneering breakthroughs in their fields. Their investment strategy also emphasizes long-term involvement, often supporting founders through multiple funding rounds and connecting them with a strong network of co-investors across Europe and the U.S. The fund's leadership team, alongside Macfarlane, includes seasoned professionals who bring expertise from venture capital and deep-tech industries.

CreatorLed Ventures is a Los Angeles-based venture capital firm founded in 2022 that sits at the intersection of venture capital and the creator economy. Co-founded by General Partners Blake Michael and Eric Kullberg — both founders, operators, and creators who have built audiences and businesses themselves — the firm backs early-stage startups and brings something traditional VCs typically cannot: direct access to highly engaged creator audiences that portfolio companies can tap for go-to-market execution. The firm invests at pre-seed and seed stages with checks of $100,000 to $1 million, focusing on fintech, consumer crypto, Web3, marketplaces, edtech, gaming, prosumer software, and health and wellness. Portfolio companies include Kendal, Hedge, and Parthean — spanning productivity software, brokerage, and educational software. With 3 investments across these categories, CreatorLed operates as a focused, founder-first fund targeting companies where distribution through creator channels can provide a meaningful competitive advantage. CreatorLed Ventures' core thesis is that founder-operators who have built their own audiences and businesses understand growth in ways that purely financial investors do not. The firm's team comprises founders, operators, and creators, and its value proposition extends beyond capital to include genuine audience access and community leverage at the earliest and most critical stages of company building.

Crédit Mutuel Equity, the private equity arm of Crédit Mutuel Alliance Fédérale, focuses on supporting companies at various stages of their development, from early-stage growth to transformation and international expansion. Based in France, the firm has a diverse portfolio encompassing over 350 companies globally. Key investments include UroMems, which develops implantable mechatronics technology for medical applications; Quandela, a leader in quantum photonics; and HarfangLab, a cybersecurity company specializing in endpoint detection and response. Other notable companies in their portfolio are Latitude, a space launcher operator, and MentorShow, an EdTech SaaS platform. Crédit Mutuel Equity invests across multiple sectors, including healthcare, technology, consumer goods, energy, real estate, and logistics. They typically support companies with innovative business models and substantial growth potential, providing both financial investment and strategic guidance to help them scale and succeed.

Credo Ventures is a Prague-based venture capital firm founded in 2009, focused on early-stage investments in technology startups within Central and Eastern Europe. They invest in a variety of sectors, including AI, medtech, edtech, and software. Their portfolio includes notable companies like Eleven Labs, Upheal, and Mewery. Credo Ventures typically invests in pre-seed and seed stages, with initial investments ranging up to €5 million. They currently manage €250 million across four funds, with their latest fund being €75 million. Their strategy is to back passionate founders from the ideation stage through to achieving product-market fit and beyond, providing both financial support and strategic guidance. The leadership team includes experienced partners like Jan Habermann, Lukas Hurych, and Vladislav Jez, who bring extensive experience in entrepreneurship and venture capital. They focus on building long-term relationships with founders and helping them navigate the challenges of scaling their businesses globally. Geographically, Credo Ventures targets startups from Central and Eastern European countries such as the Czech Republic, Poland, Hungary, and Romania, aiming to support their expansion into global markets.

Creeris Ventures is a New York-based venture builder and investment firm that creates, funds, and operates companies under its own control rather than investing passive capital in externally originated startups. Founded in 2015, the firm identifies solid ideas and sound market fundamentals, then builds businesses from the ground up with an emphasis on strategy and execution. The model is closer to a company studio than a traditional fund, with Creeris taking an active operational role throughout a portfolio company's development. The firm's focus spans high-performance computing, big data, life sciences, real estate, gaming and entertainment, and health and fitness — sectors where foundational technology advantages can be built early and protected. Creeris deploys seed and early-stage capital, with checks from $500,000 to $3 million, continuing with growth capital as each business matures. Across 13 portfolio companies, the firm leads its positions and maintains deep engagement with management teams at every stage. With a core team of two partners and one principal, Creeris operates as a concentrated, hands-on venture studio that prizes operational depth over portfolio breadth. The firm's approach reflects the view that the best outcomes come from building with founders rather than simply backing them, and from committing the firm's own expertise and time alongside its capital.

Crescendo Venture Partners (CR-VP) is a Tel Aviv-based venture capital firm focused on investing in early-stage companies that leverage next-generation technologies such as Big Data, AI, and Machine Learning. Founded by a team of seasoned venture capitalists with over 75 years of combined experience, CR-VP seeks to partner with ambitious entrepreneurs who aim to build sustainable, profitable businesses that can become category leaders in their respective industries. The firm emphasizes supporting startups that offer simple, scalable solutions to complex problems across substantially-sized markets. CR-VP's approach involves not only providing capital but also offering strategic support to help companies navigate the journey from inception to exit. CR-VP's portfolio includes notable companies like WalkMe, which went public, and Cyota, which was acquired by RSA. The firm also collaborates with the Geneva-based Crescendo Group, providing access to untapped sources of capital and broadening the reach to European, LATAM, and Asian markets.

Crescent Capital, founded in 1995 and headquartered in Belfast, Northern Ireland, is a venture capital firm that focuses on early-stage and growth investments in technology, life sciences, and manufacturing sectors. They have a strong track record of supporting innovative SMEs and high-growth potential companies. Some of their notable investments include GoReport, a market-leading digital building surveying software developer, and Twiga Foods, a prominent food distribution platform in Kenya. Crescent Capital has also invested in other impactful companies such as Replify, Datactics, and Voscuris. Their recent funding initiatives include the Crescent Capital IV fund, which offers investments of up to £5 million to support companies in their growth phases​​. Crescent Capital's strategic approach involves not only providing financial support but also leveraging their expertise and network to help portfolio companies scale and succeed in global markets. The firm is committed to fostering entrepreneurship and driving private sector growth, contributing significantly to the local and international business ecosystems​.

Crescent Ridge VC is a private, evergreen, female-led venture capital firm founded in 2012 and based in Solana Beach, Southern California. Founded by Allison, with Maria joining as partner in 2020, the firm backs mission-driven founders with early-stage capital, strategic guidance, and aligned networks. As a permanent capital vehicle rather than a traditional ten-year fund, Crescent Ridge can take a longer view on portfolio companies and maintain relationships through multiple growth cycles. The firm invests at Seed and Series A stages with checks of $500,000 to $3 million, focusing on health and wellness, sustainability, consumer goods, and software. With 19 portfolio companies, Crescent Ridge has built a track record across these four sectors, backing founders who believe that commercial success and positive social impact are mutually reinforcing rather than competing objectives. The firm's concentrated Southern California base gives it strong roots in a region with a growing mission-driven startup community. Cresident Ridge's investment thesis holds that values-driven entrepreneurs will outperform the market over the long run — a conviction that shapes both which founders the firm backs and how it engages with them as partners. The firm provides not just capital but access to networks of like-minded industry leaders and operators who share its orientation toward building companies that endure.

Crew Capital is a community-driven venture capital firm founded in 2020 by Brandon Deer and Daniel Dines, both prominent figures from UiPath. The firm is headquartered in San Francisco, California, and focuses on providing active operational support to portfolio companies, setting it apart from traditional VC models. Crew Capital's first fund, raised in 2021, amounted to $50 million. This fund supports investments in early-stage startups, helping them scale through a network-driven approach. Crew Capital invests across various regions including the U.S., Europe, Israel, and Latin America, targeting transformative businesses that have the potential to redefine their respective industries. Their portfolio includes notable companies such as BetterUp, Chainalysis, Cedar, and Spring Health. The firm's unique approach involves active involvement from founders who have significant experience in scaling successful companies, ensuring portfolio companies receive unparalleled support and guidance​.

Crista Galli Ventures is a London-based evergreen venture capital fund founded in 2019, operating as the healthtech investment arm of IPQ Capital — the family office of Dr Fiona Pathiraja and Søren Fryland Møller, who serve as the fund's two partners. Also active from Copenhagen, the firm focuses on European healthtech startups led by clinicians and domain experts, investing at the nexus of biology, technology, and medicine. The evergreen structure allows the fund to maintain long-term positions and support founders through extended development timelines typical of healthcare innovation. Crista Galli invests at Seed and Series A stages, writing checks from €100,000 to £3 million, across digital health, AI-enabled clinical tools, medical devices, and personalized medicine. With 48 investments across the UK, Germany, France, Spain, and the Netherlands, the portfolio includes Bugbiome, Kanjo Health, CardiaTec, Inne, Keleya, Leda Health, and aeon — spanning fertility, cardiology, digital therapeutics, and wearable health monitoring. The firm's clinical and scientific credibility is central to its value proposition. Dr Pathiraja's background as a physician-investor enables Crista Galli to evaluate clinical validity and adoption potential in ways that purely financial investors cannot. The fund backs companies with strong user adoption potential and genuine capacity to solve real-world healthcare problems at scale.

Cross Creek is a venture capital firm based in Salt Lake City, Utah, with a distinctive focus on late-stage growth companies that are poised to transition from private to public markets. Founded by Karey Barker in 2006, originally within Wasatch Advisors, the firm became an independent entity in 2012. Cross Creek's strategy revolves around investing in companies with proven business models and established market potential, capturing value as they scale towards IPOs or strategic acquisitions. Their portfolio includes notable names like GitLab, Dataminr, and Pindrop, reflecting their investment in sectors such as enterprise software, healthcare, and consumer tech. With over 100 investments, 27 IPOs, and 36 M&A exits, Cross Creek's approach combines public market insights with venture capital expertise, enabling them to bridge the gap between late-stage funding and public exits. The firm is headquartered outside the typical venture hubs, giving it a unique perspective. According to Barker, being based in Utah allows Cross Creek to avoid groupthink and strategically identify underappreciated opportunities, leveraging the burgeoning "Silicon Slopes" tech ecosystem. They believe that Utah's growing innovation culture, combined with their focus on diversity in hiring and thought leadership, sets them apart. Cross Creek’s ability to invest alongside top-tier venture funds while also making direct investments has allowed them to manage over $1.3 billion in assets, making a substantial impact on the venture ecosystem​.

Cross Ocean Ventures (COV) is an early-stage venture capital firm founded in 2022 with a dual presence in San Diego, California and Amsterdam, Netherlands. Co-founded by Milan Saes, Serhat Pala, and Zeynep Ilgaz — a team with over 100 years of combined experience in business management, commercialization, and investment — the firm focuses exclusively on ambitious technology companies that have originated in Europe or Israel and are ready to expand into the US market. COV positions itself as the premier fund for international founders with global ambitions. The firm leads rounds and writes checks of $100,000 to $750,000 at pre-seed through Series A, concentrating on digital health, B2B SaaS, and digital identity. The portfolio of 11 companies includes FenixPyre, Alpha3D, and HoustonBionics, spanning cybersecurity, AI-generated content, and medical technology. COV's specific goal is to help European and Israeli startups position for Series A funding from US investors within 12 to 24 months of initial investment, providing hands-on commercial and strategic support through that transition. The firm invests across a wide European geography including Israel, Germany, Belgium, Estonia, Finland, Ireland, the Netherlands, Norway, Turkey, and the UK. Its transatlantic structure gives portfolio companies direct access to US networks from their earliest growth stages, addressing the market entry challenge that derails many technically strong international startups.

Crossbeam Venture Partners is a venture capital firm that specializes in investing in pre-seed and Series A startups focused on the future economy. With a strong emphasis on platform economies, fintech, emerging asset classes, and new media, Crossbeam supports innovative companies poised to reshape industries. Notable investments include startups like Spotter, Acquco, and QuickNode, reflecting the firm’s commitment to scalability and high-growth potential. Founded by Ali Hamed and Chris Ryan, Crossbeam goes beyond traditional investing by offering founders strategic guidance, industry connections, and hands-on support. The firm is known for its deep involvement with portfolio companies, helping them navigate the complexities of scaling businesses in competitive sectors such as Web3, remittances, and the creator economy. By focusing on high-potential business models and leveraging its team’s operational expertise, Crossbeam has played a pivotal role in guiding startups through their growth phases. Crossbeam recently raised a $70 million fund, which strengthens its ability to support early-stage companies focused on long-term value creation. The firm operates primarily out of New York and San Francisco, but its investment reach extends globally, particularly in sectors like fintech and logistics. With a reputation for collaboration and adaptability, Crossbeam continues to support visionary founders aiming to redefine the economic landscape.

Crosscut Ventures, based in Los Angeles, is a leading seed-stage venture capital firm. Founded in 2008 by Brian Garrett and Rick Smith, Crosscut focuses on partnering with early-stage founders to build high-growth tech companies. The firm invests in a range of industries including digital media, enterprise SaaS, e-commerce, and fintech. Notable investments in Crosscut's portfolio include companies like GumGum, Pacaso, and SteadyMD. They have also seen successful exits with companies such as HelloTech, Comparably, and StarMaker Interactive. Crosscut typically invests between $250,000 and $750,000 in early-stage companies that have the potential to scale rapidly and disrupt their industries. Crosscut is deeply rooted in the Los Angeles tech ecosystem, leveraging their extensive network and expertise to support startups. They are known for their founder-first approach, emphasizing empathy and long-term partnership. This is reflected in their commitment to founder health and wellness, dedicating at least one percent of all capital invested towards leadership development and mental health support for founders.

Crosslink Capital, founded in 1989, is an early-stage venture capital firm based in Menlo Park and San Francisco. The firm focuses on investing in disruptive and market-transforming companies across enterprise and consumer technology sectors. As of April 2024, Crosslink closed its tenth flagship venture capital fund, Crosslink Ventures X, with $350 million in capital commitments, maintaining its focus on backing early-stage entrepreneurs from pre-seed through Series A stages​. A key component of Crosslink's strategy is the Alpha Network, an invite-only community of over 2,000 founders, CEOs, investors, and operators, established by General Partner Eric Chin in 2005. This network facilitates more than 40 annual events, including thematic discussions, networking parties, investor summits, and conferences, providing a rich ecosystem of support for founders. In conjunction with the recent fundraise, Crosslink has added Anduena Zhubi as the Director of Business Development, aimed at enhancing post-investment support for portfolio companies. Zhubi brings extensive industry experience from her previous roles at Microsoft and its venture arm, M12.

Crossover VC is an early-stage venture capital firm that provides diversified access to high-potential investments in the private technology sector. Founded by Noah Lichtenstein, the firm focuses on backing pre-seed and seed-stage funds, particularly those led by founders and operators with proven track records. Crossover VC is committed to identifying and supporting top technical founders who are poised to lead in their respective sectors. Their investment strategy is deeply rooted in the belief that micro-VC funds, led by experienced operators, will continue to outperform traditional venture capital firms. They are sector-agnostic, though they have a strong preference for post-traction Seed and Series A opportunities where the founding team's unique strengths can significantly accelerate growth. Crossover VC’s portfolio includes investments in innovative companies such as Clubhouse, Life360, and Sundae. With a diverse investor base that includes family offices, financial institutions, tech executives, and even professional athletes, Crossover VC offers a broad network of resources to its portfolio companies. The firm is based in San Francisco and is led by a team of industry veterans who bring decades of experience in both entrepreneurship and investing. This hands-on approach and commitment to fostering long-term partnerships make Crossover VC a key player in the venture capital landscape.

Crossroad Venture Capital Fund (Crossroad FCP) is a Luxembourg-based open-ended venture capital fund whose units are listed on the Luxembourg Stock Exchange, making it one of the few publicly traded early-stage venture vehicles in Europe. Founded in 2010 and backed by the Generali Insurance Group as its primary LP, the fund focuses exclusively on early-stage Israeli companies with unique intellectual property, exceptional management teams, and strong potential for market penetration and growth. Generali's permanent capital backing gives Crossroad a longer investment horizon than typical closed-end funds. The fund invests at pre-seed and seed stages, deploying $1 million to $10 million per company across medical devices, information and communications technology, renewable energy, biotechnology, and pharmaceuticals. With 15 investments spanning healthtech, AI, biotech, energy, and pharma, Crossroad covers Israel's strongest technology sectors. The fund leverages Generali's multinational network and strategic relationships to add value beyond capital — particularly in commercialization support for Israeli companies seeking to scale into European markets. Crossroad's structure as a listed, open-ended fund backed by one of Europe's largest insurance groups differentiates it meaningfully in the Israeli deep tech ecosystem. This combination of stock exchange liquidity, permanent capital, and a marquee corporate LP provides portfolio companies with a credible long-term institutional partner at the earliest stages of company development.

Crowberry Capital, a venture capital firm based in Reykjavik, Iceland, and Copenhagen, Denmark, focuses on seed and early-stage investments in the Nordic region. Founded by Helga Valfells, Hekla Arnardottir, and Jenny Ruth Hrafnsdottir, the firm aims to support innovative and high-potential startups across various sectors, including technology, digital health, and gaming. The firm has raised Iceland’s largest VC fund, a $90 million vehicle, which supports their mission to back diverse and bold entrepreneurs. Crowberry Capital’s portfolio includes notable companies such as Mainframe Industries, a gaming studio developing cloud-native social sandbox MMO Pax Dei; Lucinity, an AI-powered anti-money laundering platform; and Garden.io, which automates cloud development processes. Other investments include companies like Dreamdata, which focuses on B2B revenue attribution, and Kind, a provider of digital communication tools for healthcare providers​. Crowberry Capital prides itself on a strong follow-through philosophy, offering not only capital but also strategic support to help startups scale. Their approach has attracted significant interest from US VC funds at the Series A stage, highlighting the collaborative and robust nature of the Nordic startup ecosystem​.

Crowdcube, founded in 2010, is a UK-based equity crowdfunding platform that enables individuals to invest in startups and growing businesses in return for equity. As a pioneer in this space, Crowdcube democratizes access to investment opportunities, allowing everyday investors to back ventures alongside professional investors. With over 1.1 million registered members, the platform has facilitated the funding of more than 1,000 companies, including notable names like Monzo and Revolut. The platform primarily targets early-stage and growth-stage businesses across diverse industries such as fintech, consumer products, and technology. Crowdcube has raised over $60 million in funding for itself from investors like Balderton Capital and Draper Esprit. In addition to individual investments, it recently launched Cubex, a secondary marketplace for private companies, allowing shareholders to sell their equity before a company goes public. Crowdcube's mission is to give entrepreneurs the capital they need while offering investors the chance to support businesses they believe in, with the added benefit of being part of the company’s journey. It's a leading player in Europe's equity crowdfunding space, continually evolving to meet the growing needs of both founders and investors.

Crush Ventures, the venture capital arm of Crush Music, focuses on early-stage investments at the intersection of media, culture, and technology. With a portfolio that includes 25 companies, Crush Ventures invests in startups poised to impact pop culture significantly. Notable investments include Sound, a blockchain-based music platform, and MELON, a web development company for PC games. Their portfolio also features KYX World, a fashion retail startup, and Audioshake, an AI-driven music technology company. The firm emphasizes supporting ventures that innovate within the music and entertainment industries. Primarily investing in the United States, Crush Ventures leads funding rounds with typical check sizes ranging from $1 million to $5 million. They offer not only capital but also leverage their extensive network and expertise in talent management to provide strategic support. This hands-on approach is evident in partnerships like the one with Dance Church for Sia’s music promotions and the launch of Miley Cyrus’s at-home tan product line, Dolce Glow. The leadership team includes veterans from Crush Music, such as Jonathan Daniel and Bob McLynn, who have a proven track record of building and managing major music talents like Miley Cyrus and Green Day. Their extensive experience in the entertainment industry provides startups with unparalleled access to marketing, branding, and distribution networks. Crush Ventures prefers to invest in innovative, tech-driven startups that align with their focus on pop culture and media. Entrepreneurs looking to partner with Crush Ventures should demonstrate a clear potential to disrupt and engage with mainstream audiences effectively​.

CRV (formerly Charles River Ventures) is a well-established venture capital firm, founded in 1970, that focuses on early-stage investments in both enterprise and consumer technology startups. With over five decades of experience, CRV has supported the growth of more than 600 companies, including major successes like DoorDash, Airtable, Postman, and HubSpot. The firm is known for its hands-on approach and long-term commitment to helping founders build transformative companies. CRV typically leads investments and prides itself on moving quickly, often providing a term sheet within 24 hours. The firm aims to be a founder's first check, backing ambitious projects even in their earliest stages. They invest across various sectors, from enterprise software to consumer products, with notable focus areas like APIs (Postman), cloud networking (Aviatrix), and no-code solutions (Airtable). The firm’s investment ethos is built on forming deep, lasting partnerships with entrepreneurs, helping them navigate challenges and scale their businesses. CRV has offices in San Francisco and Palo Alto, California, with a team of partners experienced in working with startups through both good times and bad.

Crystal Horse Investments (CHI) is a Singapore-based venture capital firm with a focus on early-stage, angel, and seed investments. Established to support innovative startups across Southeast Asia, CHI has built a strong reputation for identifying high-potential companies, particularly in the technology, mobile, gaming, and web-based sectors. The firm actively participates in early funding rounds, including pre-seed, seed, and occasionally Series A, offering startups the critical capital and guidance they need to scale rapidly in competitive markets. Beyond just financial investment, CHI operates as an incubator, providing hands-on mentorship and strategic support to its portfolio companies. Startups benefit from Crystal Horse’s extensive network, industry insights, and operational expertise, allowing them to accelerate growth and navigate common early-stage challenges. The firm also collaborates with government initiatives such as Singapore’s iJam Reload program, which aims to nurture the next generation of tech innovators by providing incubation, mentorship, and early-stage funding opportunities. CHI has backed a diverse range of companies, from mobile app developers to cutting-edge web technology firms. With a strong belief in fostering innovation, CHI is committed to supporting entrepreneurs who are building the future of Southeast Asia’s digital economy. Their flexible investment approach, coupled with deep market knowledge, makes Crystal Horse a valuable partner for startups aiming to disrupt industries and scale regionally.

CSC Upshot Ventures, founded in 2015, is an early-stage venture capital firm based in Palo Alto, California. The firm focuses on providing seed capital to technology companies across sectors like artificial intelligence, fintech, enterprise software, and healthcare. CSC Upshot was formed through a partnership with AngelList and the CSC Group, a Chinese investment powerhouse, making it a unique cross-border fund with a strong connection between U.S. tech innovation and Asian capital markets. CSC Upshot has built a portfolio that includes numerous unicorns, such as Kin, an online platform for homeowner insurance, and Roofstock, a marketplace for real estate investment. The firm has a track record of scaling startups, with investments spanning over 350 companies and several successful exits, including BioAge Labs and OpenGov. CSC Upshot is known for its institutional approach to seed-stage investing, writing initial checks that typically range from $100,000 to $250,000, aiming to bridge the gap between seed and Series A rounds. Led by Ming Yeh and supported by a global team, CSC Upshot leverages its expertise in connecting U.S. and Asian markets, bringing strategic value to its portfolio companies. The firm’s goal is to help founders not only secure capital but also access the global resources needed for long-term growth.

Cultivation Capital is a venture capital firm focused on early-stage investing, primarily at the Seed and Series A phases, with initial investments ranging from $100,000 to $3.5 million. Founded in 2012, the firm manages a family of funds targeting sectors such as life sciences and health tech, software and IT, agriculture and food tech, and geospatial technology. The firm has a mission to advance entrepreneurs with capital, counsel, and support while exceeding investors' expectations and creating opportunities for its team through career advancement and community impact. The firm operates several specialized funds, including partnerships with entities like the Yield Lab for Food and AgTech investments, and has backed over 120 startups. Notable investments include companies in diverse sectors such as therapeutics, diagnostics, precision agriculture, and location intelligence. Cultivation Capital is committed to building an inclusive portfolio, having invested in startups across more than 25 states and countries. The leadership team includes experienced venture capitalists and industry experts like co-founders Cliff Holekamp and Brian Matthews, as well as general partners and advisors with extensive backgrounds in their respective fields. The firm emphasizes active involvement with its portfolio companies, often taking board positions to provide strategic guidance and leverage their network of partners and investors.

Cultivian Sandbox Ventures is a venture capital firm dedicated to investing in innovative startups within the food and agriculture sectors. Founded in 2008 and headquartered in Chicago, the firm focuses on technologies that enhance crop production, animal health, food safety, and sustainability​. The firm has a robust portfolio featuring companies such as Vestaron, which is leading advancements in peptide-based crop protection, Supergut, offering functional food products for gut health, and Sound Agriculture, which develops products to help plants utilize soil nutrients more effectively​​. They also back companies like Geltor, which produces animal-free protein ingredients, and Full Harvest, a B2B marketplace for surplus produce​ (Cultivian Sandbox Ventures)​. Cultivian Sandbox Ventures recently closed its third fund at $135 million, with prominent investors including Archer Daniels Midland, Corteva Agriscience, and Ecolab. This fund focuses on Series A and B deals, with a global investment scope, looking particularly at synthetic biology, AI, and advanced materials​​. The team is led by experienced professionals like Andy Ziolkowski, who has over 30 years in venture capital and merchant banking, and Dan Phillips, who emphasizes the firm's commitment to platform technologies with multiple market applications​.

Cure Kids Ventures (CKV) is a seed and early-stage venture capital fund based in Auckland, New Zealand, established in 2008 as part of Cure Kids, a leading child health research charity. CKV invests in the commercialization of innovations that have the potential to improve child health globally. The fund focuses on healthcare-related sectors, including medical devices, biotechnology, diagnostics, medications, and health information systems. Its mission aligns closely with Cure Kids’ vision of a healthier future for children, supporting solutions that can make a significant impact on pediatric care​. CKV typically invests in pre-seed, seed, and Series A rounds, with initial investments ranging from under $500,000 to $3 million. The fund is highly selective, emphasizing strong commercialization potential. CKV has built an impressive portfolio, backing companies like the a2 Milk Company, Pictor, and The Clinician, which are making waves in health tech and biotech industries. Their investments are strategically aimed at driving innovations that address critical health challenges faced by children. The team at CKV brings global experience in biotechnology and healthcare, providing not only financial backing but also valuable insights into early-stage development and commercialization. CKV has played a crucial role in fostering the growth of New Zealand’s healthcare innovation ecosystem, and its impact extends beyond capital, as it works closely with startups to help them achieve market success.